(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate(CAS: 33069-62-4)
![(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate](https://cnstatic.chemtradehub.com/structs/330/33069-62-4-4aa0.webp)
CAS号
相关产品
其他供应商提供的 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate
基本信息
分子式
C47H51NO14
分子量
853.92 g/mol
物理状态
Powder
Physical Properties
熔点
213-216 ºC
沸点
957.1°C at 760 mmHg
闪点
9℃
化学标识符
SMILES
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7
InChIKey
RCINICONZNJXQF-MZXODVADSA-N
数据库引用
MDL号
MFCD00869953
Beilstein登记号
1420457
常见问题
紫杉醇是一种从红豆杉树皮和木材中提取的天然抗癌药物,CAS号为33069-62-4。其化学结构包含一个复杂的多环体系,由两个六元环通过桥头连接形成,侧链上带有乙酰氧基、羟基和苯甲酸酯基团。该化合物通过抑制微管解聚,稳定细胞分裂过程,从而发挥抗肿瘤作用,是治疗多种癌症的重要药物。
紫杉醇主要用于治疗乳腺癌、卵巢癌、肺癌、淋巴瘤等恶性肿瘤。作为细胞周期抑制剂,它通过干扰癌细胞的微管功能,阻止细胞分裂,诱导程序性死亡。此外,其衍生物如多西他赛也被广泛应用于临床,常与其他化疗药物联合使用以提高疗效。
紫杉醇作为处方药需在医生指导下使用,其安全性与剂量和个体差异相关。常见不良反应包括骨髓抑制、神经毒性、过敏反应及低血压,使用时需监测血常规和肝肾功能。操作人员应佩戴防护手套、口罩等避免接触,孕妇及哺乳期妇女禁用。需严格遵循医疗规范以减少风险。
紫杉醇应储存于阴凉、干燥、避光的环境中,温度控制在2-8℃,避免高温和潮湿。需密封保存于棕色玻璃瓶或金属容器中,防止光照降解。储存时远离强酸、强碱等腐蚀性物质,确保通风良好。运输和保管过程中需避免剧烈震动,保持包装完整。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序

![Sodium {1-[({(1R)-1-{3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]phenyl}-3-[2-(2-hydroxy-2-propanyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetate](https://cnstatic.chemtradehub.com/structs/151/151767-02-1-cd5b.webp)

![8-Chloro-11-{1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene}-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (2E)-2-butenedioate (1:1)](https://cnstatic.chemtradehub.com/structs/182/182349-12-8-b7f7.webp)
![1-[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N-methylmethanamine hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/866/866783-13-3-60e4.webp)

![2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide](https://cnstatic.chemtradehub.com/structs/133/133099-07-7-e564.webp)
![2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid](https://cnstatic.chemtradehub.com/structs/144/144060-53-7-2f9c.webp)
![1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-7-indolinecarboxamide](https://cnstatic.chemtradehub.com/structs/160/160970-54-7-1c54.webp)
![{(11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/140/140462-76-6-f733.webp)
![(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate — 南京普怡生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecda42b2de6e8e95a5fa6/67cecda42b2de6e8e95a5fa6-logo.webp)
![(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate — 湖北扬信医药科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)